Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Br J Haematol Retrieve available abstracts of 189 articles: HTML format Text format

Single Articles

December 2011
1. PORTELL CA , Sekeres MA, Rogers HJ, Tiu RV, et al
   De Novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.
   Br J Haematol. 2011 Dec 8. doi: 10.1111/j.1365-2141.2011.08972.
   PubMed     Text format     Related articles   
   
   
   
   November 2011
2. GIBSON BE , Webb DK, Howman AJ, De Graaf SS, et al
   Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial.
   Br J Haematol. 2011;155:366-76.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. WAN TS , Ma ES, Chen YT
   Near-tetraploid acute myeloid leukaemia.
   Br J Haematol. 2011;155:285.
   PubMed     Text format     Related articles   
   
   
   
   
4. SHEEN C , Vincent T, Barrett D, Horwitz EM, et al
   Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis.
   Br J Haematol. 2011;155:403-7.
   PubMed     Text format     Related articles   
   
   
   
   October 2011
5. TADMOR T , Bejar J, Attias D, Polliack A, et al
   Richter syndrome in chronic lymphocytic leukaemia manifesting only as tumorous hepatomegaly.
   Br J Haematol. 2011;155:135.
   PubMed     Text format     Related articles   
   
   
   
   
6. ANDERSEN MK , Autio K, Barbany G, Borgstrom G, et al
   Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
   Br J Haematol. 2011;155:235-43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. NORDIGARDEN A , Zetterblad J, Trinks C, Green H, et al
   Irreversible pan-ERBB inhibitor canertinib elicits anti-leukaemic effects and induces the regression of FLT3-ITD transformed cells in mice.
   Br J Haematol. 2011;155:198-208.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. BECKER PS , Kantarjian HM, Appelbaum FR, Petersdorf SH, et al
   Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.
   Br J Haematol. 2011;155:182-9.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. RIPPERGER T , Tauscher M, Praulich I, Pabst B, et al
   Constitutional trisomy 8p11.21-q11.21 mosaicism: a germline alteration predisposing to myeloid leukaemia.
   Br J Haematol. 2011;155:209-17.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. FRANDSEN TL , Abrahamsson J, Lausen B, Vettenranta K, et al
    Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study.
    Br J Haematol. 2011;155:244-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. FORRESTER AM , Grabher C, McBride ER, Boyd ER, et al
    NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
    Br J Haematol. 2011;155:167-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
12. LATAGLIATA R , Breccia M, Fazi P, Vignetti M, et al
    GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors.
    Br J Haematol. 2011;154:564-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. RINALDI A , Mian M, Kwee I, Rossi D, et al
    Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemia.
    Br J Haematol. 2011;154:590-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. RIVES S , Estella J, Gomez P, Lopez-Duarte M, et al
    Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperati
    Br J Haematol. 2011;154:600-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. RANA SK , Das-Gupta E, Sovani V, O'Connor S, et al
    Unusual nodular bone marrow appearances in a case of myeloid sarcoma.
    Br J Haematol. 2011;154:544.
    PubMed     Text format     Related articles   
    
    
    
    
16. OGURA M , Todo T, Tanaka M, Nannya Y, et al
    Temozolomide may induce therapy-related acute lymphoblastic leukaemia.
    Br J Haematol. 2011;154:663-5.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
17. BHATTACHARYA N , Diener S, Idler IS, Rauen J, et al
    Nurse-like cells show deregulated expression of genes involved in immunocompetence.
    Br J Haematol. 2011;154:349-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. DE WEER A , Van der Meulen J, Rondou P, Taghon T, et al
    EVI1-mediated down regulation of MIR449A is essential for the survival of EVI1 positive leukaemic cells.
    Br J Haematol. 2011;154:337-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. STEVENS J , Waters R, Sieniawska C, Kassam S, et al
    Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies.
    Br J Haematol. 2011;154:448-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. SCHINDLER J , Gajavelli S, Ravandi F, Shen Y, et al
    A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia.
    Br J Haematol. 2011;154:471-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. O'CONNOR D , Sibson K, Caswell M, Connor P, et al
    Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia.
    Br J Haematol. 2011;154:482-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. ALVARES CL , Schenk T, Hulkki S, Min T, et al
    Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations.
    Br J Haematol. 2011;154:457-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
23. AL-SHIEBAN S , Byrne E, Trivedi P, Morilla R, et al
    Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.
    Br J Haematol. 2011 Jul 2. doi: 10.1111/j.1365-2141.2011.08760.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. HODGSON K , Ferrer G, Pereira A, Moreno C, et al
    Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.
    Br J Haematol. 2011;154:14-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. QASIM W , Derniame S, Gilmour K, Chiesa R, et al
    Third-party virus-specific T cells eradicate adenoviraemia but trigger bystander graft-versus-host disease.
    Br J Haematol. 2011;154:150-3.
    PubMed     Text format     Related articles   
    
    
    
    
26. BUGGINS AG , Levi A, Gohil S, Fishlock K, et al
    Evidence for a macromolecular complex in poor prognosis CLL that contains CD38, CD49d, CD44 and MMP-9.
    Br J Haematol. 2011;154:216-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. HASLE H , Niemeyer CM
    Advances in the prognostication and management of advanced MDS in children.
    Br J Haematol. 2011;154:185-95.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. CROWTHER-SWANEPOEL D , Di Bernardo MC, Jamroziak K, Karabon L, et al
    Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk.
    Br J Haematol. 2011;154:229-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. CENCINI E , Sozzi E, Sicuranza A, Fabbri A, et al
    A pilot monocentric analysis of efficacy and safety of Fludarabine-Campath combination (Flucam) as first line treatment in elderly patients with chronic lymphocytic leukaemia and Tp53 disfunction.
    Br J Haematol. 2011;154:271-4.
    PubMed     Text format     Related articles   
    
    
    
    
30. ABURAWI HE , Biloglav A, Johansson B, Paulsson K, et al
    Cytogenetic and molecular genetic characterization of the 'high hyperdiploid' B-cell precursor acute lymphoblastic leukaemia cell line MHH-CALL-2 reveals a near-haploid origin.
    Br J Haematol. 2011;154:275-7.
    PubMed     Text format     Related articles   
    
    
    
    
31. GENDERS RE , Vermeer MH, van Doorn R
    Erythematous and purpuric plaques of the face and scalp in Sweet syndrome.
    Br J Haematol. 2011;154:159.
    PubMed     Text format     Related articles   
    
    
    
    June 2011
32. CZUCZMAN MS , Vose JM, Witzig TE, Zinzani PL, et al
    The differential effect of lenalidomide monotherapy in patients with relapsed or refractory transformed non-Hodgkin lymphoma of distinct histological origin.
    Br J Haematol. 2011 Jun 28. doi: 10.1111/j.1365-2141.2011.08781.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. SEKIMIZU M , Sunami S, Nakazawa A, Hayashi Y, et al
    Chromosome abnormalities in advanced stage T-cell lymphoblastic lymphoma of children and adolescents: a report from Japanese Paediatric Leukaemia/Lymphoma Study Group (JPLSG) and review of the literature.
    Br J Haematol. 2011 Jun 21. doi: 10.1111/j.1365-2141.2011.08788.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. CHEN KW , Yang CF, Huang CT, Chiou TJ, et al
    Molluscum contagiosum in a patient with adult T-cell leukaemia/lymphoma.
    Br J Haematol. 2011 Jun 17. doi: 10.1111/j.1365-2141.2011.08776.
    PubMed     Text format     Related articles   
    
    
    
    
35. WICKREMASINGHE RG , Prentice AG, Steele AJ
    Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets.
    Br J Haematol. 2011;153:545-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. DUQUE-AFONSO J , Solari L, Essig A, Berg T, et al
    Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiation.
    Br J Haematol. 2011;153:612-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. BUTCHER CM , Neufing PJ, Eriksson L, Carmichael CL, et al
    RUNX1 mutations are rare in chronic phase polycythaemia vera.
    Br J Haematol. 2011;153:672-5.
    PubMed     Text format     Related articles   
    
    
    
    
38. YAMAZAKI S , Nakamura F, Nasu R, Nannya Y, et al
    Haemophagocytic lymphohistiocytosis is a recurrent and specific complication of acute erythroid leukaemia.
    Br J Haematol. 2011;153:669-72.
    PubMed     Text format     Related articles   
    
    
    
    
39. UCKUN FM , Qazi S, Ozer Z, Garner AL, et al
    Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network.
    Br J Haematol. 2011;153:741-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. CORKERY DP , Dellaire G, Berman JN
    Leukaemia xenotransplantation in zebrafish--chemotherapy response assay in vivo.
    Br J Haematol. 2011;153:786-9.
    PubMed     Text format     Related articles   
    
    
    
    
41. OUANSAFI I , Arabadjief M, Mathew S, Srivastara S, et al
    Myeloid sarcoma with t(11;19)(q23;p13.3) (MLL-ELL) in the uterine cervix.
    Br J Haematol. 2011;153:679.
    PubMed     Text format     Related articles   
    
    
    
    
42. XIONG Y , Li Z, Ji M, Tan AC, et al
    MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML.
    Br J Haematol. 2011;153:753-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
43. KITAWAKI T , Kadowaki N, Fukunaga K, Kasai Y, et al
    A phase I/IIa clinical trial of immunotherapy for elderly patients with acute myeloid leukaemia using dendritic cells co-pulsed with WT1 peptide and zoledronate.
    Br J Haematol. 2011;153:796-9.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
44. LEADER A , Lishner M, Michaeli J, Revel A, et al
    Fertility considerations and preservation in haemato-oncology patients undergoing treatment.
    Br J Haematol. 2011;153:291-308.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. IANNITTO E , Morabito F, Mancuso S, Gentile M, et al
    Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study.
    Br J Haematol. 2011;153:351-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. WU X , Smoley SA, Peterson MA, Walters DK, et al
    Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cells.
    Br J Haematol. 2011;153:402-5.
    PubMed     Text format     Related articles   
    
    
    
    
47. NAKAYAMA-ICHIYAMA S , Yokote T, Iwaki K, Takubo T, et al
    Progression of chronic myelomonocytic leukaemia to acute myeloid leukaemia with expression of tumour necrosis factor-alpha and its receptors.
    Br J Haematol. 2011;153:419.
    PubMed     Text format     Related articles   
    
    
    
    
48. PORAKISHVILI N , Memon A, Vispute K, Kulikova N, et al
    CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.
    Br J Haematol. 2011;153:486-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. OSSENKOPPELE GJ , van de Loosdrecht AA, Schuurhuis GJ
    Review of the relevance of aberrant antigen expression by flow cytometry in myeloid neoplasms.
    Br J Haematol. 2011;153:421-36.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. ADVANI AS , Gibson S, Douglas E, Diacovo J, et al
    Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
    Br J Haematol. 2011;153:504-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. MAJID A , Richards T, Dusanjh P, Kennedy DB, et al
    TP53 codon 72 polymorphism in patients with chronic lymphocytic leukaemia: identification of a subgroup with mutated IGHV genes and poor clinical outcome.
    Br J Haematol. 2011;153:533-5.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
52. DEARDEN CE , Johnson R, Pettengell R, Devereux S, et al
    Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).
    Br J Haematol. 2011 Apr 11. doi: 10.1111/j.1365-2141.2011.08651.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. BAI LY , Ma Y, Kulp SK, Wang SH, et al
    OSU-DY7, a novel D-tyrosinol derivative, mediates cytotoxicity in chronic lymphocytic leukaemia and Burkitt lymphoma through p38 mitogen-activated protein kinase pathway.
    Br J Haematol. 2011 Apr 7. doi: 10.1111/j.1365-2141.2010.08443.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. ERNST T , Score J, Deininger M, Hidalgo-Curtis C, et al
    Identification of FOXP1 and SNX2 as novel ABL1 fusion partners in acute lymphoblastic leukaemia.
    Br J Haematol. 2011;153:43-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. WOEI-A-JIN S , Ypma P, van den Biesen P
    Bilateral optic nerve infiltration in a patient with acute myeloid leukaemia.
    Br J Haematol. 2011;153:2.
    PubMed     Text format     Related articles   
    
    
    
    
56. DOMENECH C , Thomas X, Chabaud S, Baruchel A, et al
    l-asparaginase loaded red blood cells in refractory or relapsing acute lymphoblastic leukaemia in children and adults: results of the GRASPALL 2005-01 randomized trial.
    Br J Haematol. 2011;153:58-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
57. SOKOL L , Caceres G, Volinia S, Alder H, et al
    Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes.
    Br J Haematol. 2011;153:24-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. RICCIONI R , Pelosi E, Riti V, Castelli G, et al
    Immunophenotypic features of acute myeloid leukaemia patients exhibiting high FLT3 expression not associated with mutations.
    Br J Haematol. 2011;153:33-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. UCKUN FM , Sun L, Qazi S, Ma H, et al
    Recombinant human CD19-ligand protein as a potent anti-leukaemic agent.
    Br J Haematol. 2011;153:15-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. SAMAAN S , Guerin-El Khourouj V, Auboeuf D, Peltier L, et al
    Outcome of children treated with haematopoietic-stem cell transplantations from donors expressing the rare C77G variant of the PTPRC (CD45) gene.
    Br J Haematol. 2011;153:47-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. DAL-BO M , Del Giudice I, Bomben R, Capello D, et al
    B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usage.
    Br J Haematol. 2011;153:3-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. THOMPSON PD , Wade R, Richards S, Gibson BE, et al
    No association of HLA-A supertype with outcome in childhood acute lymphoblastic leukaemia: results of the UKALL XI trial.
    Br J Haematol. 2011;153:131-3.
    PubMed     Text format     Related articles   
    
    
    
    
63. BACHY E , Bernaud J, Roy P, Rigal D, et al
    Quantitative and functional analyses of CD4(+) CD25(+) FoxP3(+) regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate.
    Br J Haematol. 2011;153:139-43.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
64. PATEL H , Nteliopoulos G, Nikolakopoulou Z, Jackson A, et al
    Antibody arrays identify protein-protein interactions in chronic myeloid leukaemia.
    Br J Haematol. 2011;152:611-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. POLLYEA DA , Kohrt HE, Medeiros BC
    Acute myeloid leukaemia in the elderly: a review.
    Br J Haematol. 2011;152:524-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. RAMACHANDRAN J , Kelly R, Bowen D, Gilleece M, et al
    Micromegakaryocytes in CSF.
    Br J Haematol. 2011;152:503.
    PubMed     Text format     Related articles   
    
    
    
    
67. ASTWOOD E , Vora A
    Personal practice: how we manage the risk of bleeding and thrombosis in children and young adults with acute lymphoblastic leukaemia.
    Br J Haematol. 2011;152:505-11.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. PICHLER MM , Bodner C, Fischer C, Deutsch AJ, et al
    Evaluation of mutations in the isocitrate dehydrogenase genes in therapy-related and secondary acute myeloid leukaemia identifies a patient with clonal evolution to IDH2 R172K homozygosity due to uniparental disomy.
    Br J Haematol. 2011;152:669-72.
    PubMed     Text format     Related articles   
    
    
    
    
69. MOLGAARD-HANSEN L , Mottonen M, Glosli H, Jonmundsson GK, et al
    Treatment-related deaths in second complete remission in childhood acute myeloid leukaemia.
    Br J Haematol. 2011;152:623-30.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. KUCHINSKAYA E , Heyman M, Nordgren A, Soderhall S, et al
    Interphase fluorescent in situ hybridization deletion analysis of the 9p21 region and prognosis in childhood acute lymphoblastic leukaemia (ALL): results from a prospective analysis of 519 Nordic patients treated according to the NOPHO-ALL 2000 protoc
    Br J Haematol. 2011;152:615-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. HILLMEN P , Cohen DR, Cocks K, Pettitt A, et al
    A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
    Br J Haematol. 2011;152:570-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. MESSINA M , Chiaretti S, Iacobucci I, Tavolaro S, et al
    AICDA expression in BCR/ABL1-positive acute lymphoblastic leukaemia is associated with a peculiar gene expression profile.
    Br J Haematol. 2011;152:727-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. LOH ML
    Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia.
    Br J Haematol. 2011;152:677-87.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. VAN GALEN KP , Zweegman S, Ossenkoppele GJ
    Pancreatic pseudocyst in an adult patient after treatment with pegylated asparaginase.
    Br J Haematol. 2011;152:676.
    PubMed     Text format     Related articles   
    
    
    
    
75. BACHER U , Haferlach T, Alpermann T, Zenger M, et al
    Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.
    Br J Haematol. 2011;152:713-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
76. LEHRNBECHER T , Schubert R, Allwinn R, Dogan K, et al
    Revaccination of children after completion of standard chemotherapy for acute lymphoblastic leukaemia: a pilot study comparing different schedules.
    Br J Haematol. 2011;152:754-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. THORN I , Forestier E, Botling J, Thuresson B, et al
    Minimal residual disease assessment in childhood acute lymphoblastic leukaemia: a Swedish multi-centre study comparing real-time polymerase chain reaction and multicolour flow cytometry.
    Br J Haematol. 2011;152:743-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
78. NAKAYAMA-ICHIYAMA S , Yokote T, Hiraoka N, Takubo T, et al
    Expression of multiple cytokines and cutaneous lymphocyte antigen in adult T-cell leukaemia/lymphoma cells with tumour progression and skin involvement.
    Br J Haematol. 2011 Feb 20. doi: 10.1111/j.1365-2141.2011.08584.
    PubMed     Text format     Related articles   
    
    
    
    
79. DEARDEN C
    Large granular lymphocytic leukaemia pathogenesis and management.
    Br J Haematol. 2011;152:273-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
80. BHADRI VA , Satharasinghe K, Sugo E, Barbaric D, et al
    Excellent response to dasatinib of childhood Philadelphia positive intracranial acute lymphoblastic leukaemia tumours.
    Br J Haematol. 2011;152:347-9.
    PubMed     Text format     Related articles   
    
    
    
    
81. PATZ M , Isaeva P, Forcob N, Muller B, et al
    Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.
    Br J Haematol. 2011;152:295-306.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. RASI S , Spina V, Bruscaggin A, Vaisitti T, et al
    A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome.
    Br J Haematol. 2011;152:284-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. VAN TILBURG CM , Sanders EA, Nibbelke EE, Pieters R, et al
    Impact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*.
    Br J Haematol. 2011;152:433-40.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
84. GRACE RF , Dahlberg SE, Neuberg D, Sallan SE, et al
    The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.
    Br J Haematol. 2011;152:452-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. NOORDERMEER SM , Tonnissen E, Vissers I, van der Heijden A, et al
    Rapid identification of IDH1 and IDH2 mutations in acute myeloid leukaemia using high resolution melting curve analysis.
    Br J Haematol. 2011;152:493-6.
    PubMed     Text format     Related articles   
    
    
    
    
86. SULE U , Muge G, Selin AE, Murat T, et al
    Mild to fatal course of pandemic influenza H1N1 in children with acute leukaemia.
    Br J Haematol. 2011;152:492-3.
    PubMed     Text format     Related articles   
    
    
    
    January 2011
87. DUCASSOU S , Ferlay C, Bergeron C, Girard S, et al
    Clinical presentation, evolution, and prognosis of precursor B-cell lymphoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951.
    Br J Haematol. 2011 Jan 7. doi: 10.1111/j.1365-2141.2010.08541.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
88. ELLIOTT SL , Crawford C, Mulligan E, Summerfield G, et al
    Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia.
    Br J Haematol. 2011;152:61-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. BRECCIA M , Orlandi SM, Latagliata R, Grammatico S, et al
    Suboptimal response to imatinib according to 2006-2009 European LeukaemiaNet criteria: a 'grey zone' at 3, 6 and 12 months identifies chronic myeloid leukaemia patients who need early intervention.
    Br J Haematol. 2011;152:119-21.
    PubMed     Text format     Related articles   
    
    
    
    
90. IMAIZUMI M , Tawa A, Hanada R, Tsuchida M, et al
    Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study.
    Br J Haematol. 2011;152:89-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
91. SIAPATI EK , Papadaki M, Kozaou Z, Rouka E, et al
    Proliferation and bone marrow engraftment of AML blasts is dependent on beta-catenin signalling.
    Br J Haematol. 2011;152:164-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
92. MARSCHALEK R
    Mechanisms of leukemogenesis by MLL fusion proteins.
    Br J Haematol. 2011;152:141-54.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
93. FRENZEL LP , Patz M, Pallasch CP, Brinker R, et al
    Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis.
    Br J Haematol. 2011;152:191-200.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
94. ADVANI AS , Gundacker HM, Sala-Torra O, Radich JP, et al
    Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
    Br J Haematol. 2010;151:430-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
95. POL RR , Wright A, Hill A
    Daunorubicin-induced hyperpigmentation.
    Br J Haematol. 2010;151:414.
    PubMed     Text format     Related articles   
    
    
    
    
96. RAPANOTTI MC , Caruso R, Ammatuna E, Zaza S, et al
    Molecular characterization of paediatric idiopathic hypereosinophilia.
    Br J Haematol. 2010;151:440-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
97. PEREZ B , Kosmider O, Cassinat B, Renneville A, et al
    Genetic typing of CBL, ASXL1, RUNX1, TET2 and JAK2 in juvenile myelomonocytic leukaemia reveals a genetic profile distinct from chronic myelomonocytic leukaemia.
    Br J Haematol. 2010;151:460-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
98. MOLGAARD-HANSEN L , Mottonen M, Glosli H, Jonmundsson GK, et al
    Early and treatment-related deaths in childhood acute myeloid leukaemia in the Nordic countries: 1984-2003.
    Br J Haematol. 2010;151:447-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
99. LINDEN T , Schnittger S, Groll AH, Juergens H, et al
    Childhood B-cell precursor acute lymphoblastic leukaemia in a patient with familial thrombocytopenia and RUNX1 mutation.
    Br J Haematol. 2010;151:528-30.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
100. CURRY S , Bacon CL, Robinson I, Capra M, et al
     Leukaemic alveolar rhabdomyosarcoma.
     Br J Haematol. 2010;151:208.
     PubMed     Text format     Related articles   
     
     
     
     
101. POGGI A , Prevosto C, Catellani S, Rocco I, et al
     Engagement of CD31 delivers an activating signal that contributes to the survival of chronic lymphocytic leukaemia cells.
     Br J Haematol. 2010;151:252-64.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
102. VALCECKIENE V , Kontenyte R, Jakubauskas A, Griskevicius L, et al
     Selection of reference genes for quantitative polymerase chain reaction studies in purified B cells from B cell chronic lymphocytic leukaemia patients.
     Br J Haematol. 2010;151:232-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
103. SADIK W , Coupland S, Thachil J
     Hairy cell leukaemia, negative for conventional cell markers, diagnosed using antibodies to annexin A1 and T-bet.
     Br J Haematol. 2010;151:207.
     PubMed     Text format     Related articles   
     
     
     
     
104. CASTLETON AZ , Brazma D, Howard-Reeves J, Chanalaris A, et al
     Genome gains at chromosome 21q21/22 segment leads to co-amplification of Down Syndrome Critical Regions and known oncogenes in a case of donor cell-derived acute myeloid leukaemia following allogeneic sex mismatched umbilical cord blood transplantatio
     Br J Haematol. 2010;151:285-8.
     PubMed     Text format     Related articles   
     
     
     
     
105. NAJFELD V , Tripodi J, Scalise A, Silverman LR, et al
     Jumping translocations of the long arms of chromosome 1 in myeloid malignancies is associated with a high risk of transformation to acute myeloid leukaemia.
     Br J Haematol. 2010;151:288-91.
     PubMed     Text format     Related articles   
     
     
     
     
106. LUESINK M , Jansen JH
     Advances in understanding the pulmonary infiltration in acute promyelocytic leukaemia.
     Br J Haematol. 2010;151:209-20.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
107. GELSI-BOYER V , Trouplin V, Roquain J, Adelaide J, et al
     ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia.
     Br J Haematol. 2010;151:365-75.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
108. ZHENG C , Liu X, Zhu W, Wu J, et al
     Strategy to further increase of cure rate in acute promyelocytic leukaemia: low-dose all-trans retinoic acid and sequential maintenance cycle.
     Br J Haematol. 2010;151:406-9.
     PubMed     Text format     Related articles   
     
     
     
     
109. LEE-SHERICK AB , Linger RM, Gore L, Keating AK, et al
     Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development.
     Br J Haematol. 2010;151:295-311.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
110. CHOUDHURY A , Derkow K, Daneshmanesh AH, Mikaelsson E, et al
     Silencing of ROR1 and FMOD with siRNA results in apoptosis of CLL cells.
     Br J Haematol. 2010;151:327-35.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
111. SPORTOLETTI P , Baldoni S, Cavalli L, Del Papa B, et al
     NOTCH1 PEST domain mutation is an adverse prognostic factor in B-CLL.
     Br J Haematol. 2010;151:404-6.
     PubMed     Text format     Related articles   
     
     
     
     
112. SETLUR SR , Ihm C, Tchinda J, Shams S, et al
     Comparison of familial and sporadic chronic lymphocytic leukaemia using high resolution array comparative genomic hybridization.
     Br J Haematol. 2010;151:336-45.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     October 2010
113. DAI Y , Guzman ML, Chen S, Wang L, et al
     The NF (Nuclear factor)-kappaB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.
     Br J Haematol. 2010;151:70-83.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
114. REINDL L , Bacher U, Dicker F, Alpermann T, et al
     Biological and clinical characterization of recurrent 14q deletions in CLL and other mature B-cell neoplasms.
     Br J Haematol. 2010;151:25-36.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
115. SPEARS MD , Harrington AM, Kroft SH, Olteanu H, et al
     Immunophenotypic stability of T-cell large granular lymphocytic leukaemia by flow cytometry.
     Br J Haematol. 2010;151:97-9.
     PubMed     Text format     Related articles   
     
     
     
     
116. TORELLI GF , Natalino F, Barberi W, Maggio R, et al
     Clinical responses in allografted acute leukaemia patients with resistant disease using a combined chemo-immunotherapeutic treatment strategy.
     Br J Haematol. 2010;151:86-9.
     PubMed     Text format     Related articles   
     
     
     
     
117. MALONE A , Langabeer S, O'Marcaigh A, Storey L, et al
     A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia.
     Br J Haematol. 2010;151:101-2.
     PubMed     Text format     Related articles   
     
     
     
     
118. DI VEROLI A , Ramadan SM, Divona M, Cudillo L, et al
     Molecular remission in advanced acute promyelocytic leukaemia after treatment with the oral synthetic retinoid Tamibarotene.
     Br J Haematol. 2010;151:99-101.
     PubMed     Text format     Related articles   
     
     
     
     
119. BEST OG , Singh N, Forsyth C, Mulligan SP, et al
     The novel Hsp-90 inhibitor SNX7081 is significantly more potent than 17-AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway.
     Br J Haematol. 2010;151:185-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
120. GOLDIN LR , Lanasa MC, Slager SL, Cerhan JR, et al
     Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families.
     Br J Haematol. 2010;151:152-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
121. RODRIGUEZ-ROMO L , Mancias-Guerra C, Gonzalez-Llano O, Jaime-Perez JC, et al
     Outpatient reduced intensity conditioning allogeneic stem cell transplantation for acute myeloid leukaemia in children.
     Br J Haematol. 2010;151:200-2.
     PubMed     Text format     Related articles   
     
     
     
     
122. BUCHNER M , Brantner P, Stickel N, Prinz G, et al
     The microenvironment differentially impairs passive and active immunotherapy in chronic lymphocytic leukaemia - CXCR4 antagonists as potential adjuvants for monoclonal antibodies.
     Br J Haematol. 2010;151:167-78.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
123. DEFOICHE J , Zhang Y, Lagneaux L, Willems L, et al
     In vivo ribosomal RNA turnover is down-regulated in leukaemic cells in chronic lymphocytic leukaemia.
     Br J Haematol. 2010;151:192-5.
     PubMed     Text format     Related articles   
     
     
     
     
124. HARRISON CJ , Haas O, Harbott J, Biondi A, et al
     Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group.
     Br J Haematol. 2010;151:132-42.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
125. IZRAELI S
     Application of genomics for risk stratification of childhood acute lymphoblastic leukaemia: from bench to bedside?
     Br J Haematol. 2010;151:119-31.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     September 2010
126. KUGLER M , Stein C, Kellner C, Mentz K, et al
     A recombinant trispecific single-chain Fv derivative directed against CD123 and CD33 mediates effective elimination of acute myeloid leukaemia cells by dual targeting.
     Br J Haematol. 2010;150:574-86.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
127. GERBER B , Nair G, Stussi G
     Erythroblastic islands.
     Br J Haematol. 2010;150:499.
     PubMed     Text format     Related articles   
     
     
     
     
128. JONES CD , Arai S, Lowsky R, Tyan DB, et al
     Complete donor T-cell engraftment 30 days after allogeneic transplantation predicts molecular remission in high-risk chronic lymphocytic leukaemia.
     Br J Haematol. 2010;150:637-9.
     PubMed     Text format     Related articles   
     
     
     
     
129. PHILIPPEN A , Diener S, Zenz T, Dohner H, et al
     SYK carries no activating point mutations in patients with chronic lymphocytic leukaemia (CLL).
     Br J Haematol. 2010;150:633-6.
     PubMed     Text format     Related articles   
     
     
     
     
130. HUTTER C , Attarbaschi A, Fischer S, Meyer C, et al
     Acute monocytic leukaemia originating from MLL-MLLT3-positive pre-B cells.
     Br J Haematol. 2010;150:621-3.
     PubMed     Text format     Related articles   
     
     
     
     
131. DE VRIES JF , Te Marvelde JG, Wind HK, van Dongen JJ, et al
     The potential use of basigin (CD147) as a prognostic marker in B-cell precursor acute lymphoblastic leukaemia.
     Br J Haematol. 2010;150:624-6.
     PubMed     Text format     Related articles   
     
     
     
     
132. CALVO-VILLAS JM , Fernandez JA, de la Fuente I, Godoy AC, et al
     Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.
     Br J Haematol. 2010;150:618-20.
     PubMed     Text format     Related articles   
     
     
     
     
133. MORENO DA , Scrideli CA, Cortez MA, de Paula Queiroz R, et al
     Differential expression of HDAC3, HDAC7 and HDAC9 is associated with prognosis and survival in childhood acute lymphoblastic leukaemia.
     Br J Haematol. 2010;150:665-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
134. BUDA G , Carulli G, Orciuolo E, Cannizzo E, et al
     CD23 expression in plasma cell leukaemia.
     Br J Haematol. 2010;150:724-5.
     PubMed     Text format     Related articles   
     
     
     
     August 2010
135. SPIRA D , Vogel W, Bares R, Horger M, et al
     Volume-perfusion CT as an adjunct to whole-body contrast-enhanced CT for monitoring response to therapy in lymphoma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
136. SANTOS FP , Kantarjian H, Fava C, O'Brien S, et al
     Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia.
     Br J Haematol. 2010;150:303-12.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
137. OKU S , Takenaka K, Kuriyama T, Shide K, et al
     JAK2 V617F uses distinct signalling pathways to induce cell proliferation and neutrophil activation.
     Br J Haematol. 2010;150:334-44.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
138. MUSSAI F , Campana D, Bhojwani D, Stetler-Stevenson M, et al
     Cytotoxicity of the anti-CD22 immunotoxin HA22 (CAT-8015) against paediatric acute lymphoblastic leukaemia.
     Br J Haematol. 2010;150:352-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
139. GROVDAL M , Karimi M, Khan R, Aggerholm A, et al
     Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
     Br J Haematol. 2010;150:293-302.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
140. CARMICHAEL CL , Wilkins EJ, Bengtsson H, Horwitz MS, et al
     Poor prognosis in familial acute myeloid leukaemia with combined biallelic CEBPA mutations and downstream events affecting the ATM, FLT3 and CDX2 genes.
     Br J Haematol. 2010;150:382-5.
     PubMed     Text format     Related articles   
     
     
     
     
141. SHER T , Miller KC, Deeb G, Lee K, et al
     Plasma cell leukaemia and other aggressive plasma cell malignancies.
     Br J Haematol. 2010;150:418-27.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
142. BORRO M , Gentile G, De Luca O, Torre MS, et al
     Specific effects exerted by B-lymphoproliferative diseases on peripheral T-lymphocyte protein expression.
     Br J Haematol. 2010;150:463-72.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
143. ROWE JM
     Prognostic factors in adult acute lymphoblastic leukaemia.
     Br J Haematol. 2010;150:389-405.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
144. TEGG EM , Thomson RJ, Stankovich J, Banks A, et al
     Evidence for a common genetic aetiology in high-risk families with multiple haematological malignancy subtypes.
     Br J Haematol. 2010;150:456-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
145. CROWTHER-SWANEPOEL D , Mansouri M, Enjuanes A, Vega A, et al
     Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk.
     Br J Haematol. 2010;150:473-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
146. OLTEANU H , Harrington AM, Ramirez S, Kroft SH, et al
     Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia.
     Br J Haematol. 2010;150:480-1.
     PubMed     Text format     Related articles   
     
     
     
     July 2010
147. JEREZ A , Del Mar Osma M, Amigo ML, Ortuno FJ, et al
     Faggot cells in an HIV-positive patient with inv(16)/therapy-related acute myeloid leukaemia.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
148. BO MD , Secchiero P, Degan M, Marconi D, et al
     MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3.
     Br J Haematol. 2010;150:237-9.
     PubMed     Text format     Related articles   
     
     
     
     
149. DAWSON MA , Curry JE, Barber K, Beer PA, et al
     AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders.
     Br J Haematol. 2010;150:46-57.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
150. KAHL C , Freund M
     Peripheral blood alterations in a patient with infectious mononucleosis.
     Br J Haematol. 2010;150:2.
     PubMed     Text format     Related articles   
     
     
     
     
151. ROSENBERG PS , Zeidler C, Bolyard AA, Alter BP, et al
     Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy.
     Br J Haematol. 2010;150:196-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
152. KADIA TM , Yang H, Ferrajoli A, Maddipotti S, et al
     A phase I study of vorinostat in combination with idarubicin in relapsed or refractory leukaemia.
     Br J Haematol. 2010;150:72-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
153. COIFFIER B , Losic N, Ronn BB, Lepretre S, et al
     Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study.
     Br J Haematol. 2010;150:58-71.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
154. SUGIMOTO Y , Muramatsu H, Makishima H, Prince C, et al
     Spectrum of molecular defects in juvenile myelomonocytic leukaemia includes ASXL1 mutations.
     Br J Haematol. 2010;150:83-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
155. POLONI A , Capelli D, Trappolini S, Costantini B, et al
     Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study.
     Br J Haematol. 2010;150:119-21.
     PubMed     Text format     Related articles   
     
     
     
     
156. BRECCIA M , Bocchia M, Cannella L, Defina M, et al
     Reduction of imatinib dose and persistence of complete molecular response after p210 multipeptide vaccine in chronic myeloid leukaemia treated with dose escalation for acquired resistance.
     Br J Haematol. 2010;150:240-2.
     PubMed     Text format     Related articles   
     
     
     
     
157. ZUCCHETTO A , Tripodo C, Benedetti D, Deaglio S, et al
     Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38(+)CD49d(+) chronic lymphocytic leukaemia cells.
     Br J Haematol. 2010;150:111-3.
     PubMed     Text format     Related articles   
     
     
     
     
158. DE FRIAS M , Iglesias-Serret D, Cosialls AM, Gonzalez-Girones DM, et al
     Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells.
     Br J Haematol. 2010;150:108-11.
     PubMed     Text format     Related articles   
     
     
     
     June 2010
159. MCNEER JL , Nachman JB
     The optimal use of steroids in paediatric acute lymphoblastic leukaemia: no easy answers.
     Br J Haematol. 2010;149:638-52.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
160. QAZI S , Uckun FM
     Gene expression profiles of infant acute lymphoblastic leukaemia and its prognostically distinct subsets.
     Br J Haematol. 2010;149:865-73.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
161. OGAWA E , Yagasaki H, Kato M, Shichino H, et al
     Successful treatment of disseminated intravascular coagulation in a child with acute myelogenous leukaemia using recombinant thrombomodulin.
     Br J Haematol. 2010;149:911-2.
     PubMed     Text format     Related articles   
     
     
     
     
162. MATTHEWS K , Lim Z, Pearce L, Pagliuca A, et al
     Rapid recovery of lymphocyte subsets is not associated with protection from relapse of myelodysplastic syndromes and acute myeloid leukaemia after haematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab.
     Br J Haematol. 2010;149:879-89.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
163. LAUNES C , Rives S, Catala A, Berrueco R, et al
     Pandemic influenza A (2009 H1N1) in children with acute lymphoblastic leukaemia.
     Br J Haematol. 2010;149:874-8.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
164. EDEN TO , Pieters R, Richards S
     Systematic review of the addition of vincristine plus steroid pulses in maintenance treatment for childhood acute lymphoblastic leukaemia - an individual patient data meta-analysis involving 5,659 children.
     Br J Haematol. 2010;149:722-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
165. KRISHNAN B , Else M, Tjonnfjord GE, Cazin B, et al
     Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study.
     Br J Haematol. 2010;149:907-10.
     PubMed     Text format     Related articles   
     
     
     
     
166. HERISHANU Y , Eshel R, Kay S, Rothman R, et al
     Unexpected detection of monoclonal B-cell lymphocytosis in a HLA-matched sibling donor on the day of allogeneic stem cell transplantation for a patient with chronic lymphocytic leukaemia: clinical outcome.
     Br J Haematol. 2010;149:905-7.
     PubMed     Text format     Related articles   
     
     
     
     
167. NIE YL , Jan SL, Fu LS, Chang TK, et al
     Congestive heart failure as presentation of acute lymphoblastic leukaemia with eosinophilia.
     Br J Haematol. 2010;149:633.
     PubMed     Text format     Related articles   
     
     
     
     
168. LIGHTFOOT TJ , Roman E, Smith MT, Skibola CF, et al
     Acute lymphoblastic leukaemia in children - is there a role for MTHFR?
     Br J Haematol. 2010;149:797-8.
     PubMed     Text format     Related articles   
     
     
     
     May 2010
169. COMMANDER LA , Seif AE, Insogna IG, Rheingold SR, et al
     Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
170. NAKAYAMA-ICHIYAMA S , Yokote T, Hiraoka N, Takayama A, et al
     Central nervous system involvement in adult T-cell lymphoma diagnosed with T-cell receptor gene clonality testing of cerebrospinal fluid.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     April 2010
171. BLUM KA , Liu Z, Lucas DM, Chen P, et al
     Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
172. PRATT G , Fenton JA, Allsup D, Fegan C, et al
     A polymorphism in the 3' UTR of IRF4 linked to susceptibility and pathogenesis in chronic lymphocytic leukaemia and Hodgkin lymphoma has limited impact in multiple myeloma.
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     March 2010
173. TRAVERSE-GLEHEN A , Baseggio L, Callet-Bauchu E, Ffrench M, et al
     Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?
     Br J Haematol. 2010.
     PubMed     Text format     Related articles   
     
     
     
     
174. WONG KF , Yu PH
     Erythrophagocytic megakaryoblasts in acute megakaryoblastic leukaemia.
     Br J Haematol. 2010;148:672.
     PubMed     Text format     Related articles   
     
     
     
     
175. STEIN C , Kellner C, Kugler M, Reiff N, et al
     Novel conjugates of single-chain Fv antibody fragments specific for stem cell antigen CD123 mediate potent death of acute myeloid leukaemia cells.
     Br J Haematol. 2010;148:879-89.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
176. LUCK SC , Russ AC, Du J, Gaidzik V, et al
     KIT mutations confer a distinct gene expression signature in core binding factor leukaemia.
     Br J Haematol. 2010;148:925-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
177. MIYAUCHI J , Ito Y, Tsukamoto K, Takahashi H, et al
     Blasts in transient leukaemia in neonates with Down syndrome differentiate into basophil/mast-cell and megakaryocyte lineages in vitro in association with down-regulation of truncated form of GATA1.
     Br J Haematol. 2010;148:898-909.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
178. FOSTER N , Paulsson K, Sales M, Cunningham J, et al
     Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia.
     Br J Haematol. 2010;148:938-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
179. SCOTT BL , Ramakrishnan A, Storer B, Becker PS, et al
     Prolonged responses in patients with MDS and CMML treated with azacitidine and etanercept.
     Br J Haematol. 2010;148:944-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
180. HUBMANN R , Duchler M, Schnabl S, Hilgarth M, et al
     NOTCH2 links protein kinase C delta to the expression of CD23 in chronic lymphocytic leukaemia (CLL) cells.
     Br J Haematol. 2010;148:868-78.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
181. ANDERSSON TM , Lambert PC, Derolf AR, Kristinsson SY, et al
     Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study.
     Br J Haematol. 2010;148:918-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
182. LAUTER A , Strumpf A, Platzbecker U, Schetelig J, et al
     188Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantation.
     Br J Haematol. 2010;148:910-7.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
183. IDLER I , Giannopoulos K, Zenz T, Bhattacharya N, et al
     Lenalidomide treatment of chronic lymphocytic leukaemia patients reduces regulatory T cells and induces Th17 T helper cells.
     Br J Haematol. 2010;148:948-50.
     PubMed     Text format     Related articles   
     
     
     
     
184. VOLTAN R , Celeghini C, Melloni E, Secchiero P, et al
     Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity.
     Br J Haematol. 2010;148:957-61.
     PubMed     Text format     Related articles   
     
     
     
     February 2010
185. MENG X , Martinez MA, Raymond-Stintz MA, Winter SS, et al
     IKK inhibitor bay 11-7082 induces necroptotic cell death in precursor-B acute lymphoblastic leukaemic blasts.
     Br J Haematol. 2010;148:487-90.
     PubMed     Text format     Related articles   
     
     
     
     
186. ALATRASH G , Albitar M, O'Brien S, Wang X, et al
     Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).
     Br J Haematol. 2010;148:386-93.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
187. RAI L , Casanova A, Moorman AV, Richards S, et al
     Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study.
     Br J Haematol. 2010;148:394-401.
     PubMed     Text format     Related articles    Abstract available
     
     
     
     
188. ANOOP P , Wotherspoon A, Matutes E
     Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia.
     Br J Haematol. 2010;148:484-6.
     PubMed     Text format     Related articles   
     
     
     
     November 2009
189. BURKHARDT B
     Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?
     Br J Haematol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: